DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells

Cancer Letters

Volumn 236, Issue 2, 2006, Pages 213-221

  Singh, Sandeep ^a   Chhipa, Rishi Raj ^a   Vijayakumar, Maleppillil Vavachan ^a   Bhat, Manoj Kumar ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Apoptosis; Bcl 2 promoter; DNA damage; HPV positive carcinoma

Indexed keywords

CARBOPLATIN; CASPASE 9; FLUOROURACIL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER RISK; CELL STRAIN; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; DRUG POTENCY; ENZYME ACTIVATION; ENZYME DEGRADATION; GENOTOXICITY; HEP 2 CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WART VIRUS;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBOPLATIN; CASPASE 9; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME ACTIVATION; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KB CELLS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TRANSFECTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 33646712966     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.05.024     Document Type: Article

References (25)

1. Liu X., Kim C.N., Yang J., Jemmerson R., and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86 (1996) 147-157
2. Vander Heiden M.G., and Thompson C.B. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?. Nat. Cell Biol. 1 (1999) E209-E216
3. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 39 (2003) 615-647
4. Strasser A., Huang D.C., and Vaux D.L. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochim. Biophys. Acta 1333 (1997) F151-F178
5. Vaux D.L., Cory S., and Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335 (1988) 440-442
6. Pillai M.R., Halabi S., McKalip A., Jayaprakash P.G., Rajalekshmi T.N., Nair M.K., and Herman B. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol. Biomarkers Prev. 5 (1996) 329-335
7. Pillai M.R., Jayaprakash P.G., and Nair M.K. Bcl-2 immunoreactivity but not p53 accumulation associated with tumour response to radiotherapy in cervical carcinoma. J. Cancer Res. Clin. Oncol. 125 (1999) 55-60
8. Nair P., Nair K.M., Jayaprakash P.G., and Pillai M.R. Decreased programmed cell death in the uterine cervix associated with high-risk human papillomavirus infection. Pathol. Oncol. Res. 5 (1999) 95-103
9. Kirkin V., Joos S., and Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim. Biophys. Acta 1644 (2004) 229-249
10. Ke L.D., Adler-Storthz K., Mitchell M.F., Clayman G.L., and Chen Z. Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines. Oral Oncol. 35 (1999) 415-420
11. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
12. Du J., Chen G.G., Vlantis A.C., Chan P.K., Tsang R.K., and van Hasselt C.A. Resistance to apoptosis of HPV-16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression. Cancer Lett. 205 (2004) 81-88
13. Kawakami K., Tsukuda M., Mizuno H., Nishimura G., Ishii A., and Hamajima K. Alteration of the Bcl-2/Bax status of head and neck cancer cell lines by chemotherapeutic agents. Anticancer Res. 19 (1999) 3927-3932
14. Koivusalo R., Krausz E., Ruotsalainen P., Helenius H., and Hietanen S. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand. Cancer Res. 62 (2002) 7364-7371
15. Didelot C., Mirjolet J.F., Barberi-Heyob M., Ramacci C., Teiten M.H., and Merlin J.L. Oncoprotein expression of E6 and E7 does not prevent 5-fluorouracil (5FU) mediated G1/S arrest and apoptosis in 5FU resistant carcinoma cell lines. Int. J. Oncol. 23 (2003) 81-87
16. Heckman C.A., Mehew J.W., and Boxer L.M. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 21 (2002) 3898-3908
17. Singh S., and Bhat M.K. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-κB in human HPV-18 E6 positive HEp-2 cells. Biochem. Biophys. Res. Commun. 318 (2004) 346-353
18. Chhipa R.R., Singh S., Surve S.V., Vijayakumar M.V., and Bhat M.K. Doxycycline potentiates antitumor effect of cyclophosphamide in mice. Toxicol. Appl. Pharm. 202 (2005) 268-277
19. Reed J.C. Apoptosis-targeted therapies for cancer. Cancer Cell 3 (2003) 17-22
20. Kim R., Emi M., Tanabe K., and Toge T.S. Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy. Cancer 101 (2004) 2491-2502
21. Lima R.T., Martins L.M., Guimaraes J.E., Sambade C., and Vasconcelos M.H. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Ther. 11 (2004) 309-316
22. Chen M., Quintans J., Fuks Z., Thompson C., Kufe D.W., and Weichselbaum R.R. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide. Cancer Res. 55 (1995) 991-994
23. Ochs K., and Kaina B. Apoptosis induced by DNA damage O-methylguanine is Bcl-2 and Caspase-9/3 regulated and Fas/Caspase 8 independent. Cancer Res. 60 (2000) 5815-5824
24. Milosevic J., Hoffarth S., Huber C., and Schuler M. The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases. Oncogene 22 (2003) 6852-6856
25. Feuillard J., Schuhmacher M., Kohanna S., Asso-Bonnet M., Ledeur F., Joubert-Caron R., et al. Inducible loss of NF-κB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood 95 (2000) 2068-2075